Product Images Memantine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Memantine NDC 60505-6162 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Components - Components

Components - Components

Figure1 - Figure1

Figure1 - Figure1

Figure2 - Figure2

Figure2 - Figure2

The given text represents a chart depicting the cumulative percentage of patients using Placebo and Memantine HCI drugs. The chart displays the ADCS-ADL change from the baseline and the scale ranges from -20 to 25. However, the chart does not provide sufficient information to draw any conclusion from it.*

Figure3 - Figure3

Figure3 - Figure3

Figure4 - Figure4

Figure4 - Figure4

Figure5 - Figure5

Figure5 - Figure5

This text appears to be a chart showing the mean change from baseline in ADCS-ADL score for patients given a placebo/donepezil treatment versus memantine HC/donepezil treatment over the course of 12 weeks. The chart includes two categories, "Clinical Improvement" and "Clinical Decline," and displays the values for each treatment option at weeks 2, 4, 6, 8, 10, and 12. No further information is available.*

Figure6 - Figure6

Figure6 - Figure6

Figure7 - Figure7

Figure7 - Figure7

This text represents a graph showing the mean change from baseline in SIB score over weeks of treatment for two groups. One group received placebo/donepezil and the other received Memantine HCI/Donepezil. The graph indicates that the group receiving the memantine HCI donepezil combination performed better as they experienced less clinical decline over the 24 weeks of treatment.*

Figure8 - Figure8

Figure8 - Figure8

The text describes a cumulative percentage of patients with a chart displaying two different treatments: placebo/donepezil and memantine HC/donepezil. The chart shows a line graph with a change from baseline represented by SIB. There are also some numbers on the chart axis.*

Step1 - Step1

Step1 - Step1

Step10 - Step10

Step10 - Step10

Step11 - Step11

Step11 - Step11

Step2 - Step2

Step2 - Step2

Step3 - Step3

Step3 - Step3

Step4 - Step4

Step4 - Step4

Step5 - Step5

Step5 - Step5

Step6 - Step6

Step6 - Step6

Step7 - Step7

Step7 - Step7

Step8 - Step8

Step8 - Step8

Step9 - Step9

Step9 - Step9

Bottle-label - bottle label

Bottle-label - bottle label

This is a description of a medication called Memantine Hydrochloride Oral Solution, manufactured by Apotex Corp. Each 60mL bottle contains 2 mg/mL of memantine hydrochloride. The usual dosage and full prescribing information can be found in the package insert. The medication should be stored at a temperature between 20-25°C (68-77°F) in a tightly closed container. The medication is only available through a prescription and should be kept out of reach of children. The manufacturer is located in Toronto, Ontario, Canada.*

Carton - carton

Carton - carton

This is a description of a medication called Memantine Hydrochloride Oral Solution manufactured by Apotex Corp. It is designated as B Only and has a concentration of 2g/e. The remaining text is not readable.*

Structural Formula - memantine structure

Structural Formula - memantine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.